The company’s first-quarter update emphasizes strong phase 2 results for daridorexant in children, ongoing real-world studies in patients with co-morbidities, and advancements in its sleep medicine pipeline.
Research shows that older adults with insomnia are at a higher risk of severe and prolonged depression.
By targeting insomnia and effectively treating it with CBT-I, depression can be effectively prevented by over 50% in community dwelling older adults with insomnia.
Read More
In a study of new moms with insomnia symptoms during pregnancy, benefits of CBT for sleep lasted throughout the first two years post-birth.
Read More
More than 3% of adults worldwide have unruptured blood vessel malformations in the brain called intracranial aneurysms, the majority of which will never rupture.
Read More
Patients with high ADHD-traits are less able to perform tasks involving attentional regulation or emotional control after a sleepless night, according to a new study.
Read More
Health Union, which creates condition-specific online patient communities, shared results from its Sleep Disorders In America survey.
Read More
Australian researches studied the impact of depression, anxiety, and stress on response to CBT-I, in 455 real-world insomnia patients.
Read More